Compare HCA Health Inc (HCA) vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) — how do they compare? HCA Health Inc trades at $474.89 (market cap $99.75B), while RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $37.8 (market cap $63.89B). The key difference: HCA Health Inc is the larger of the two by market cap, and RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) pays the higher dividend (2.47%). Which is the better fit depends on your goals.
| HCA | RELX | |
|---|---|---|
Market Cap | $99.75B | $63.89B |
Volume | 1,083,231 | 2,760,502 |
Sector | Health | Industrials |
52-Week High | $545.13 | $46.80 |
52-Week Low | $361.32 | $27.73 |
Typical Hold Time | 76 Days | — |
Enterprise Value | $150.29B | $75.40B |
Dividend Yield | 0.68% | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $460.75, up 0.47% today, with a bullish technical outlook and strong fundamental performance. The stock shows consistent earnings beats, with Q2 2026 EPS of $7.59 exceeding expectations. Revenue grew to $75.60 billion in 2025, and net income reached $6.78 billion. Analyst consensus is bullish, with a $461.12 price target. Recent news includes an upcoming Q3 2026 earnings call and ongoing legal investigations.
Outlook remains positive due to solid demand and cost controls, but risks include regulatory scrutiny and debt levels. The stock offers growth potential from operational efficiency, though investors should monitor legal developments and payer-mix pressures. Valuation metrics like a P/E of 15.45 suggest reasonable pricing relative to earnings.
RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.
The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)
RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.
Read more on RELX →
